Use the Search Fields to Find Information
Page 40 of 377
The endocannabinoid 2-AG protects the blood–brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines
Endocannabinoids are involved in neuroprotection through numerous biochemical pathways. We have shown that the endocannabinoid 2- arachidonoyl glycerol (2-AG) is released in mouse brain after
September 19, 2019
The Emerging Role of the Endocannabinoid System in the Sleep-Wake Cycle Modulation
The endocannabinoid system comprises amides, esters and ethers of long chain polyunsaturated fatty acids. Narachidonoylethanolamide (anandamide; ANA) and 2-arachidonoylglycerol (2-AG) are endogenous cannabinoids (endocannabinoids) ligands
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
During the last few years, the endocannabinoid system has emerged as a highly relevant topic in the scientific community. Many different regulatory actions have been
The Elusive Truth of Cannabinoids for Rheumatic Pain
Please use this link to access this publication. Abstract Purpose of Review Medical cannabis (MC) has entered mainstream medicine by a unique route. Regulatory acceptance
February 8, 2026
The electrophysiological effects of cannabidiol on action potentials and transmembrane potassium currents in rabbit and dog cardiac ventricular preparations
Abstract Cannabis use is associated with known cardiovascular side effects such as cardiac arrhythmias or even sudden cardiac death. The mechanisms behind these adverse effects
April 23, 2024
The electrophysiological effect of cannabidiol on hERG current and in guinea-pig and rabbit cardiac preparations
Abstract Interest is increasing regarding use of Cannabidiol (CBD) in companion animals due to anecdotal evidence of beneficial behavioral and health effects. The purpose of
July 1, 2024
The Efficacy of Medical Marijuana in the Treatment of Cancer-Related Pain
Please use this link to access this publication. Abstract Background: The opioid epidemic has spurred investigations for nonopioid options, yet limited research persists on medical marijuana’s
July 2, 2024
The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms
Abstract Multiple sclerosis (MS) is known as an autoimmune disease that damages the neurons in the central nervous system. MS is characterized by its most
February 29, 2024
The Efficacy of Cannabis in Oncology Patient Care and Its Anti-Tumor Effects
Simple Summary Cancer is a major disease and a leading cause of death worldwide. Improving treatment and management strategies for cancer is critical. This article
December 17, 2024
The Efficacy and Safety of Use of Cannabis and Cannabinoid Products for Pain Relief in Orthopaedic Conditions and Trauma
Abstract This systematic review examines the efficacy of medical cannabis in pain management within orthopaedic domains, including arthritis pain, postsurgical pain, back pain, and post-trauma
January 17, 2026
Page 40 of 377